UV-induced mutagenesis of human p53: Analysis using a double-selection method in yeast

Environmental and Molecular Mutagenesis

Volumn 35, Issue 1, 2000, Pages 31-38

  Moshinsky, Deborah J ^a,b   Wogan, Gerald N ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b SUGEN INC   (United States)

Author keywords

Mutagenesis; Mutation spectrum; p53; Saccharomyces cerevisiae; UV

Indexed keywords

ENVIRONMENTAL MUTAGEN; PROTEIN P53;

APOPTOSIS; ARTICLE; CARCINOGENESIS; DNA DAMAGE; GENE MUTATION; MODEL; MUTATION RATE; NONHUMAN; PHOTOREACTIVATION; RADIATION MUTAGENESIS; SACCHAROMYCES CEREVISIAE; SEQUENCE ANALYSIS; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

BASE SEQUENCE; DNA PRIMERS; GENES, P53; HUMANS; MUTAGENESIS; SACCHAROMYCES CEREVISIAE; ULTRAVIOLET RAYS;

EID: 0034002219     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(2000)35:1<31::AID-EM5>3.0.CO;2-S     Document Type: Article

References (38)

1. Amson RB, Nemani M, Roperch JP, Israeli D, Bougueleret L, Le Gall I, Medhioub M, Linares-Cruz G, Lethrosne F, Pasturaud P. Piouffre L, Prieur S, Susini L, Alvaro V, Millasseau P, Guidicelli C, Bui H, Massart C, Cases L, Dufour F, Bruzzoni-Giovanelli H, Owadi H, Hennion C, Charpak G, Telerman A, et al. 1996. Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the Drosophila seven in absentia gene. Proc Natl Acad Sci USA 93:3953-3957.
2. Armstrong JD, Kunz BA. 1992. Photoreactivation implicates cyclobutane dimers as the major promutagenic UVB lesion in yeast. Mutat Res 268:83-94.
3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, Eds. 1995. Current protocols in molecular biology. New York: John Wiley & Sons.
4. Broach JR, Strathern JN, Hicks JB. 1979. Transformation in yeast: development of a hybrid cloning vector and isolation of the CAN1 gene. Gene 8:121-133.
5. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
6. Elkeles A, Juven-Gershon T, Israeli D, Wilder S, Zalcenstein A, Oren M. 1999. The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor. Mol Cell Biol 19:2594-2600.
7. Epstein CB, Attiyeh EF, Hobson DA, Silver AL, Broach JR, Levine AJ. 1998. p53 mutations isolated in yeast based on loss of transcription factor activity: similarities and differences from p53 mutations detected in human tumors. Oncogene 16:2115-2122.
8. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher JM, Bron L, Benhattar J, et al. 1995. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92:3963-3967.
9. Flaman JM, Robert V, Lenglet S, Moreau V, Iggo R, Frebourg T. 1998. Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast. Oncogene 16:1369-1372.
10. Friedlander P, Haupt Y, Prives C, Oren M. 1996. A mutant that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol 16:4961-4971.
11. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
12. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
13. Hermann H, Häcker U, Bandlow W, Magdolen V. 1992. pYLZ vectors: Saccharomyces cerevisiae/Escherichia coli shuttle plasmids to analyze yeast promoters. Gene 119:137-141.
14. Hollstein M, Moeckel G, Hergenhahn M, Spiegelhalder B, Keil M, Werle-Schneider G, Bartsch H, Brickmann J. 1998. On the origins of tumor mutations in cancer genes: insights from the p53 gene. Mutat Res 405:145-154.
15. Inga A, Iannone R, Monti P, Molina F, Bolognesi M, Abbondandolo A, Iggo R, Fronza G. 1997. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology. Oncogene 14:1307-1313.
16. Inga A, Scott G, Monti P, Aprile A, Abbondandolo A, Burns PA, Fronza G. 1998. Ultraviolet-light induced p53 mutational spectrum in yeast is indistinguishable from p53 mutations in human skin cancer. Carcinogen 19:741-746.
17. Inga A, Chen FX, Monti P, Aprile A, Campomenosi P, Menichini P, Ottaggio L, Viaggi S, Abbondandolo A, Gold B, Fronza G. 1999. N-(2-Chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic. Cancer Res 59:689-695.
18. Ishioka C, Frebourg T, Yan YX, Vidal M, Friend SH, Schmidt S, Iggo R. 1993. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet 5:124-129.
19. Israeli D, Tessler E, Haupt Y, Elkeles A, Wilder S, Amson R, Telerman A, Oren M. 1997. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J 16:4384-4392.
20. Ivanov EL, Kovaltzova SV, Kassinova GV, Gracheva LM, Korolev VG, Zakharov IA. 1986. The rad2 mutation affects the molecular nature of UV and acridine-mustard-induced mutations in the ADE2 gene of Saccharomyces cerevisiae. Mutat Res 160:207-214.
21. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597.
22. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B. 1991. Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708-1711.
23. Ko LJ, Prives C. 1996. p53: puzzle and paradigm. Genes Dev 10:1054-1072.
24. Kunz BA, Pierce MK, Mis JRA, Giroux CN. 1987. DNA sequence analysis of the mutational specificity of u.v. light in the sup4-o gene of yeast. Mutagen 2:445-453.
25. Lee GSF, Savage EA, Ritzel RG, vonBorstel RC. 1988. The base-alteration spectrum of spontaneous and ultraviolet radiation-induced forward mutations in the URA3 locus of Saccharomyces cerevisiae. Mol Gen Genet 214:396-404.
26. Lu X, Lane DP. 1993. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75:765-778.
27. Miyashita T, Reed JC. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
28. Moshinsky DJ, Wogan GN. 1997. UV-induced mutagenesis of human p53 in a vector replicated in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 94:2266-2271.
29. Murata JI, Tada M, Iggo RD, Sawamura Y, Shinohe Y, Abe H. 1997. Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. Mutat Res 379:211-218.
30. Nemani M, Linares-Cruz G, Bruzzoni-Giovanelli H, Roperch JP, Tuynder M, Bougueleret L, Cherif D, Medhioub M, Pasturaud P, Alvaro V, der Sarkissan H, Cazes L, Le Paslier D, LeGall I, Israeli D, Dansset J, Sigaux F, Chumakov I, Oren M, Calvo F, Amson RB, Cohen D, Telerman A. 1996. Activation of the human homolgue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci USA 93:9039-9042.
31. Nigro JM, Sikorski R, Reed SI, Vogelstein B. 1992. Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. Mol Cell Biol 12:1357-1365.
32. Park DJ, Chumakov AM, Miller CW, Pham EY, Koeffler HP. 1996. p53 transactivation through various p53-responsive elements. Mol Carcinogen 16:101-108.
33. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. 1997. A model for p53-induced apoptosis. Nature 389:300-305.
34. Sage E. 1993. Distribution and repair of photolesions in DNA: genetic consequences and the role of sequence context. Photochem Photobiol 57:163-174.
35. Semenza JC, Weasel LH. 1997. Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environ Health Perspect 105:155-163.
36. Wu GS, Burns TF, McDonald ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G, el-Deiry WS. 1997. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17:141-143.
37. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
38. Yin Y, Terauchi Y, Solomon GG, Aizawa S, Rangarajan PN, Yazaki Y, Kadowaki T, Barrett JC. 1998. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 391:707-710.